Vogt Frederick G, IC, GC, reported a transaction classified as exercise at IOVANCE BIOTHERAPEUTICS, INC. involving 20835.000000 shares for an estimated $0.00. Reported holdings after the transaction were 231071.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
Stored Form 4 columns with their raw values
Badges describe filing facts only — not predictions.
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.
Form 4 relationship flags and nearby filing context
Interim CEO & General Counsel
Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.
Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.
Represents common stock remaining after deducting the common stock withheld for taxes.
Each RSU represents a contingent right to receive one share of the Issuer's common stock.
The remaining RSUs will vest in equal quarterly installments.
Such aggregate number reflects the remainder of such RSUs granted on January 14, 2022, but does not include any other RSUs held by such Reporting Person.
0 other filings
0 recent txs